Study to Find the Appropriate Dose of a New Gadolinium-based Contrast Agent (GBCA) for Adults Undergoing Magnetic Resonance Imaging (MRI) for Known or Highly Suspected Brain and/or Spinal Cord Conditions
PHASE2
Researchers in this study want to find the appropriate dose of drug BAY1747...
A Study of a Gadolinium-Based Contrast Agent (GBCA) for Adults Undergoing Magnetic Resonance Imaging (MRI) for Known or Highly Suspected Body Parts (Non-Central Nervous System) Lesions
PHASE3
The purpose of this study is to evaluate the efficacy of HRS-9231 for Magne...
Status
Completed
Location
Ruijin Hospital, Shanghai Jiaotong University School of Medicine
A Study to Compare How Well Gadoquatrane Works and Its Safety With an Already Available Contrast Agent for MRI in People With Any Known or Suspected Problems of the Body (Except Brain or Spinal Cord-related Problems)
PHASE3
Researchers are looking for a better way to help people with any known or s...